<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04105660</url>
  </required_header>
  <id_info>
    <org_study_id>2019-00132</org_study_id>
    <nct_id>NCT04105660</nct_id>
  </id_info>
  <brief_title>Electroencephalogram (EEG) in General Anaesthesia - More Than Only a Bispectral Index (BIS)</brief_title>
  <official_title>Recovery From Propofol Anaesthesia Guided by Frontal EEG Wave Analysis Compared to Bispectral Index Monitoring Alone in Laparoscopic Surgery: A Multicentre Double-blind Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cantonal Hospital of Graub端nden, Chur, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Processed electroencephalogram (EEG) monitors are routinely used in addition to clinical&#xD;
      parameters to assess the depth of anaesthesia during general anaesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Processed electroencephalogram (EEG) monitors are routinely used in addition to clinical&#xD;
      parameters to assess the depth of anaesthesia during general anaesthesia. In addition to the&#xD;
      bispectral (BIS) index displayed as an index, the raw frontal EEG can be displayed as a curve&#xD;
      on these monitors. After a short training, anaesthetists might be more accurate and faster in&#xD;
      assessing depth of anaesthesia by recognizing the pattern of the EEG curve than by using the&#xD;
      BIS index. This may further enhance the positive effects that could be demonstrated for the&#xD;
      use of BIS monitors.&#xD;
&#xD;
      Therefore, the aim of the investigator's study is to investigate the clinical relevance of&#xD;
      interpreting the raw frontal EEG in addition to only using the BIS index for titrating&#xD;
      intravenous anaesthetics.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 28, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of recovery (QoR): QoR-15 scale</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>QoR-15 scale (scale from 0 to 150; 0 means best, 150 worst recovery)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Propofol consumption</measure>
    <time_frame>during anaesthesia</time_frame>
    <description>Propofol consumption in mg/kg/h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery (QoR): QoR-15 scale</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>QoR-15 scale (scale from 0 to 150; 0 means best, 150 worst recovery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in postanaesthesia care unit (PACU)</measure>
    <time_frame>At arrival to and at discharge from postanaesthesia care unit (an average of 120 minutes)</time_frame>
    <description>Time in minutes from arrival in PACU until discharge from PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to extubation</measure>
    <time_frame>At time of skin closure and at time of extubation (an average of 90 minutes)</time_frame>
    <description>Time in minutes from skin closure to extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of awareness</measure>
    <time_frame>daily from admission up to hospital discharge, an average of approximately 14 days</time_frame>
    <description>Brice interview daily until hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aldrete score</measure>
    <time_frame>Once at discharge from postanaesthesia care unit (PACU), approximately on day 2 of admission to hospital</time_frame>
    <description>Measurement of recovery; score is 0 to 10, 0 means worst recovery, 10 means best recovery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Postoperative Nausea and Vomiting (PONV)</measure>
    <time_frame>daily from admission up to hospital discharge, an average of approximately 14 days</time_frame>
    <description>Incidence of nausea and vomiting daily until hospital discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Intervention arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EEG monitoring in addition to standard monitoring (clinical parameters and BIS index)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard monitoring including clinical parameters and BIS index</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training for EEG monitoring</intervention_name>
    <description>Training for reading EEG curves during anaesthesia</description>
    <arm_group_label>Intervention arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard monitoring</intervention_name>
    <description>Standard monitoring including clinical parameters and BIS index</description>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_label>Intervention arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients undergoing in-hospital laparoscopic abdominal surgery with general&#xD;
             anaesthesia using Propofol based on the Schnider model (target controlled infusion)42,&#xD;
             43&#xD;
&#xD;
          -  Minimal duration of surgery of 60 minutes&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Same-day surgery&#xD;
&#xD;
          -  Language barrier&#xD;
&#xD;
          -  Patients under 18 years of age&#xD;
&#xD;
          -  Pregnancy (using a beta-human chorionic gonadotropin (HCG) measurement in a blood&#xD;
             sample of women in childbearing age)&#xD;
&#xD;
          -  Allergy to Propofol&#xD;
&#xD;
          -  Administration of hypnotics other than Propofol, such as ketamine or midazolam&#xD;
             preoperatively or intraoperatively&#xD;
&#xD;
          -  Known brain pathology, such as seizure disorders, dementia, cerebrovascular disease or&#xD;
             brain death&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salome Dell-Kuster, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christoph S Burkhart, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cantonal Hospital Graub端nden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Salome Dell-Kuster, MD MSc</last_name>
    <phone>+41613286474</phone>
    <email>salome.dell-kuster@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christoph S Burkhart, MD</last_name>
    <email>christoph.burkhart@ksgr.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cantonal Hospital Aarau</name>
      <address>
        <city>Aarau</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita L端thy, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Lorenz Theiler, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cantonal Hospital Graub端nden</name>
      <address>
        <city>Chur</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Burkhart, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2019</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

